JPWO2024248079A1 - - Google Patents
Info
- Publication number
- JPWO2024248079A1 JPWO2024248079A1 JP2025524867A JP2025524867A JPWO2024248079A1 JP WO2024248079 A1 JPWO2024248079 A1 JP WO2024248079A1 JP 2025524867 A JP2025524867 A JP 2025524867A JP 2025524867 A JP2025524867 A JP 2025524867A JP WO2024248079 A1 JPWO2024248079 A1 JP WO2024248079A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023091991 | 2023-06-02 | ||
| PCT/JP2024/019828 WO2024248079A1 (en) | 2023-06-02 | 2024-05-30 | Pharmaceutical composition containing mirogabalin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2024248079A1 true JPWO2024248079A1 (en) | 2024-12-05 |
| JPWO2024248079A5 JPWO2024248079A5 (en) | 2026-03-04 |
Family
ID=93658131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025524867A Pending JPWO2024248079A1 (en) | 2023-06-02 | 2024-05-30 |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JPWO2024248079A1 (en) |
| KR (1) | KR20260018020A (en) |
| CN (1) | CN121218983A (en) |
| TW (1) | TW202513048A (en) |
| WO (1) | WO2024248079A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119732941B (en) * | 2024-12-30 | 2026-04-28 | 上海博悦生物科技有限公司 | Pharmaceutical compositions containing melogabalin besylate and their preparation methods |
| CN120531691B (en) * | 2025-06-20 | 2026-04-28 | 苏州美诺医药科技有限公司 | A merogabaline besylate solid pharmaceutical composition, formulation and preparation method thereof |
| CN121221543A (en) * | 2025-11-26 | 2025-12-30 | 华润双鹤利民药业（济南）有限公司 | A melogabalin besylate orally disintegrating tablet formulation and its preparation method |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2657219B1 (en) | 2007-09-28 | 2014-12-10 | Daiichi Sankyo Company, Limited | Intermediate for producing bicyclic y-amino acid derivative |
| CN104334169B (en) | 2013-04-04 | 2016-11-02 | 第一三共株式会社 | Solid composition comprising aminocarboxylate |
| BR112017019918B1 (en) | 2015-03-19 | 2023-11-07 | Daiichi Sankyo Company, Limited | SOLID PHARMACEUTICAL PREPARATION, AND, METHOD FOR PRODUCING A SOLID PHARMACEUTICAL PREPARATION FOR STABILIZING A SOLID PHARMACEUTICAL PREPARATION |
| BR112017019920B1 (en) | 2015-03-19 | 2023-11-07 | Daiichi Sankyo Company, Limited | SOLID PHARMACEUTICAL PREPARATION, AND METHOD FOR STABILIZING A SOLID PHARMACEUTICAL PREPARATION |
| BR112021001008A2 (en) | 2018-07-30 | 2021-04-20 | Daiichi Sankyo Company, Limited | drug tablet |
| ES3025936T3 (en) * | 2019-12-23 | 2025-06-10 | Daiichi Sankyo Co Ltd | Film-coated tablets having smooth surface |
| CN115803020A (en) * | 2020-07-27 | 2023-03-14 | 第一三共株式会社 | Orally disintegrating tablet containing milobalin besylate |
-
2024
- 2024-05-30 JP JP2025524867A patent/JPWO2024248079A1/ja active Pending
- 2024-05-30 TW TW113119971A patent/TW202513048A/en unknown
- 2024-05-30 WO PCT/JP2024/019828 patent/WO2024248079A1/en not_active Ceased
- 2024-05-30 KR KR1020257037178A patent/KR20260018020A/en active Pending
- 2024-05-30 CN CN202480035836.7A patent/CN121218983A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2024248079A1 (en) | 2024-12-05 |
| KR20260018020A (en) | 2026-02-06 |
| TW202513048A (en) | 2025-04-01 |
| CN121218983A (en) | 2025-12-26 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251128 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20251128 |